Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
for Sarcoma
Drug: Nivolumab
4 locations incl. St. Petersburg
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: All·Age: 12 Months - 40
Code: NCT03465592·Phase 1, Phase 2·Recruiting